Spyre Therapeutics (SYRE) Earnings Date & Reports

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

SYRE is expected to report earnings to rise 116.39% to -77 cents per share on November 05

Spyre Therapeutics SYRE Stock Earnings Reports

Q3'26

Est.

$-0.78

Q2'26

Beat

by $0.40

Q1'26

Missed

by $0.07

Q4'25

Est.

$-0.70

Q3'25

Beat

by $0.62

The last earnings report on August 04 showed earnings per share of -36 cents, beating the estimate of -75 cents. With 1.19M shares outstanding, the current market capitalization sits at 7.56B.

View a ticker or compare two or three

SYRE

Daily Signal:

Gain/Loss:

Biotechnologies - Trading Results
AI Trading Agent, 60min Biotechnologies - Trading Results
AI Trading Agent, 60min

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement